Both Telpopril and Dulaglutide are hypoglycemic drugs that help lower blood sugar. The main differences lie in their components, pharmacological effects, applicable conditions, and adverse reactions. It is recommended to use them under the guidance of a doctor to avoid self-medication and delaying treatment.
1. Different Components: Telpopril's main component is an amino acid polysaccharide iron complex, while Dulaglutide's main components are glargine insulin and Dulaglutide.
2. Different Pharmacological Effects: Telpopril lowers blood sugar by promoting insulin synthesis, regulating glucose utilization, and inhibiting glucagon release. Dulaglutide primarily lowers blood sugar by inhibiting incretin secretion, reducing hepatic glycogen production, and promoting glucose absorption.
3. Different Applicable Conditions: Telpopril can be used to treat type 2 diabetes, gradually lowering blood sugar and alleviating symptoms such as polydipsia, polyuria, polyphagia, and weight loss caused by insulin resistance. Dulaglutide can be used to treat type 2 diabetes and is more effective in controlling blood sugar in patients with type 2 diabetes;
4. Different adverse reactions: Telboride is prone to causing adverse reactions such as redness, swelling, and pain at the injection site. Common adverse reactions of dulaglutide include hypoglycemia, diarrhea, vomiting, nausea, rash, and itching.